Regulus Announces Pipeline Updates and Advancements
Phase II RG-012 HERA and Renal Biopsy studies for Alport syndrome move forward
Discontinuing clinical development of RG-101
Pre-clinical pipeline progresses
LA JOLLA, Calif., June 12, 2017 -- (Healthcare Sales & Marketing Network) -- Regulus Ther... Biopharmaceuticals Regulus Therapeutics, microRNAs
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news